Cross-market pharmaceutical NET price and discount benchmark panel

VAMSTARbuyer room · privateManage buyer room

Cross-market pharmaceutical NET price and discount benchmark panel: estimated net (post-discount) drug prices and gross-to-net spreads at therapy level across 40+ developed and emerging markets, on a uniform cross-market methodology, with event annotations for new launches, significant price adjustments, volume shifts and patient-support programme changes, plus a monthly analyst narrative layer explaining the drivers behind net price movements.